To provide an overview of the current state of intraoperative optical coherence tomography (OCT). Literature review of studies pertaining to intraoperative OCT examining both the technology aspects of the imaging platform and the current evidence for patient care. Over the last several years, there have been significant advances in integrative technology for intraoperative OCT. This has resulted in the development of multiple microscopeintegrated systems and a rapidly expanding field of image-guided surgical care. Multiple studies have demonstrated the potential role for intraoperative OCT in facilitating surgeon understanding of the surgical environment, tissue configuration, and overall changes to anatomy. In fact, the PIONEER and DISCOVER studies, both demonstrated a potential significant percentage of cases that intraoperative OCT alters surgical decision-making in both anterior and posterior segment surgery. Current areas of exploration and development include OCT-compatible instrumentation, automated tracking, intraoperative OCT software platforms, and surgeon feedback/visualization platforms. Intraoperative OCT is an emerging technology that holds promise for enhancing the surgical care of both anterior segment and posterior segment conditions. Hurdles remain for adoption and widespread utilization, including cost, optimized feedback platforms, and more definitive value for individualized surgical care with image guidance.
Introduction
In 1962, Thomas Kuhn coined the term 'paradigm shift' and defined it as an advancement in a field often defined by disruptive changes in methods, concepts or systems. 1 Ophthalmic surgery has experienced numerous paradigm shifts over the past several decades. In the 1960s and 1970s, new surgical systems, such as vitrectomy and phacoemulsification revolutionized anterior segment and vitreoretinal surgery. 2 In addition, visualization advances occurred in surgical microscopy, including foot-pedal control, hands-free manipulation, and wide-angle viewing systems. 3 Yet with all these advances, new cutting-edge platforms for surgical visualization are still lacking.
From the cornea to the retina to the optic nerve, optical coherence tomography (OCT) has markedly impact clinicians' approach to diagnosis, management, and surveillance of ophthalmic diseases. 4, 5 Imaging has now become ubiquitous throughout patient care. However, even in the midst of this digital revolution the application of this technology to the operating room has been slow. Optical coherence tomography provides high-resolution cross-sectional and tomographic data. Using this technology, surgeons would potentially have immediate feedback on completion of surgical objectives or new understanding of the anatomic configuration of the tissues. If used real time, OCT could provide specific guidance for surgical manipulations.
Over the past several years, the introduction of OCT into the OR has resulted in new insights into the potential roles of this technology in the surgical management of ophthalmic conditions. This review will focus on the progress in intraoperative OCT technology and potential future directions for the field.
Hurdles to utilization
An initial barrier for bringing OCT to the operating room was the lack of integrative solutions. Standard desktop systems lacked portability. In addition, the traditional chin-rest approach for image acquisition is not practical for a supine patient under sterile conditions. The general costs associated with intraoperative OCT are also a potential barrier. The OCT engine and system itself represent a significant investment. Alterations to surgical flow, such as potential delays in operating time, also may result in increased cost. Intraoperative OCT software applications are also needed to facilitate optimal interpretation and utilization of the data obtained during surgery. Finally, a limited understanding of the clinical applications of intraoperative OCT, as well as the overall value for outcomes has been a limiting factor for adoption.
Intraoperative OCT systems and devices
Standard clinical OCT systems are large and stationary, limiting their portability for operating room use. Modifications to the these table top systems can enable intraoperative imaging. However, this is logistically difficult making this approach impractical.
Portable OCT systems were the first major transformational step in intraoperative OCT. Two primary portable systems have been described in the literature: the Bioptigen EnVisu (Bioptigen, Research Triangle Park, NC/Leica, Wetzlar, Germany) and the Optovue iVue (Optovue, Fremont, CA, USA). [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Multiple approaches to image acquisition can be used with these systems, including handheld, external mounting, and microscope mounting.
Handheld imaging was the first described imaging approach with these systems. [6] [7] [8] [9] 18 Although handheld imaging may provide excellent image quality, there are significant challenges that must be considered. Handheld imaging limits image reproducibility and optimal aiming. Motion artifacts owing to limited stability can delay image acquisition and impact image quality. Maintaining a sterile surgical field may also be particularly challenging using handheld imaging.
To address many of the limitations of handheld imaging, mounting systems were developed for these portable OCT systems. 11, [13] [14] [15] [16] [17] External mounts provide improved stability but introduce an additional footprint and space requirement to the operating room. Microscope mounts allow the surgeon to fasten the portable probe directly to the microscope body ( Figure 1 ). With the probe attached to the microscope, increased stability is achieved compared with handheld imaging. In addition, the foot-pedal controls of the microscope enable X-Y-Z foot-pedal control of the probe location. This facilitates rapid imaging with enhanced image reproducibility. 13 Although portable and microscope-mounted systems are able to obtain images of excellent quality and provide surgeon feedback, all of these early systems require the surgeon to cease surgery before obtaining imaging. Although these delays have been reported to be quite minimal, a more seamless approach is needed to allow for 'real-time' imaging and minimize any surgical delay while obtaining imaging. 13 Figure 1 The next major advance in intraoperative OCT systems was the integration of the OCT and microscope optics. Adaptation of both Leica (Leica, Wetzlar, Germany) and Zeiss (Carl Zeiss Meditec, Oberkochen, Germany) were among the first systems described. [19] [20] [21] The Zeiss adaptation used a modified Cirrus (Carl Zeiss Meditec) OCT system adapted for integration into the Zeiss microscope optical path. 21 For anterior segment imaging, a modified Visante (Carl Zeiss Meditec) prototype was also integrated into a Zeiss microscope. 22, 23 Similarly, the Leica adaptation used a separate OCT scan head that was mounted to the bottom of the microscope body and integrated the optical paths of the two systems. 19, 20 These systems provided the first insights of the potential of 'real-time' intraoperative OCT allowing for OCT-based visualization of instrument-tissue interaction and immediate imaging with surgeon feedback. 21, 24 However, these systems also uncovered new challenges for intraoperative OCT development, including the need for new software systems, the limits of current instrumentation for OCT compatibility, and need for heads-up visualization. 19, 21 In addition, the need for Z axis stabilization to maximize image visualization during surgical maneuvers was identified owing to the intermittent vertical displacement that occurs during surgical maneuvers. Methods for automated tracking and/or surgeon directed maneuvering of the OCT beam to areas of interest were also lacking.
Following the development of the initial systems, second generation systems have now been developed, including the first commercially developed and approved systems. One system that has been described specifically addresses some of the shortcomings of early generation Leica add-on systems, including reduced form factor and decreased stack height ( Figure 1) . 25, 26 A tunable lens, heads-up display, and computer mouse-directed aiming provides this system with a more flexible and versatile approach to intraoperative imaging while minimizing the overall noticeable difference to the microscope footprint. 25, 26 In addition, three commercial systems have been described. The Zeiss Rescan 700 was the first FDA-cleared system and the second worldwide commercially available microscope-integrated intraoperative OCT system ( Figure 1) . 27, 28 The Rescan 700 is built on the Lumera 700 (Zeiss) microscope platform. The overall external form factor of the surgical microscope is unaltered compared with the Lumera system. The Rescan 700 combines the Callisto (Zeiss) external video control system to provide touchpad control of the OCT scanner and combined video/OCT visualization. The OCT system is also integrated into the microscope foot-pedal with surgeon directed control of aiming, orientation, and size of the OCT scan pattern. 27, 28 A heads-up display provides combined visualization of the surgical field and the OCT data stream. Anterior segment imaging and posterior segment imaging is feasible. The Rescan included one of the first Z-tracking systems for intraoperative OCT system, a significant advance for realtime intraoperative OCT. In its initial release, no analysis software was incorporated into the Rescan system and automated tracking was also not available. 27, 28 The Haag-Streit iOCT system (Haag-Streit, Koeniz, Switzerland) was the first globally commercially available and 2nd FDA-cleared microscope-integrated intraoperative OCT system. The Haag-Streit system uses a side port for OCT access using the OPMedT (OPMedT, Lubeck, Germany) OCT system, which is coupled to the microscope platform. 29 The Haag-Streit system includes both a microscope-mounted viewing screen and a head-up display screen.
In addition to the commercially available system, Bioptigen has also developed a research prototype that may be adapted to either a Leica or Zeiss scope. The Bioptigen system has been tested with a variety of features, including extended range scanning and ultra high resolution. The system uses operator driven computer-directed OCT aiming. The long-fiber optic length provides increased flexibility for placement of the OCT engine and computer within the operating room. 30 Next generation systems are currently under development. Previous systems have used spectral domain OCT technology. Swept source OCT provides a unique opportunity to address some of the current deficits in integrated OCT systems. 31 The increased acquisition speed provides for visualization of real-time three-dimensional instrument-tissue interaction. Real-time volumetric scanning at near video rates is possible given exceptional speed of the swept source system. Building on this technology, a heads-up display system has been developed that used three-dimensional technology to provide a unique surgeon feedback platform for surgeons. 31 In addition, research is needed in platform optimization and surgeon feedback systems for optimal integration and utility. Technological advances in viewing systems, optics, digital technology, and interactive platforms will continue to push the envelope of opportunities for a true seamless surgical guidance system.
Clinical use and impact
Multiple smaller studies and large-scale studies have examined the role for intraoperative OCT in various clinical conditions, both anterior and posterior segment. [6] [7] [8] [9] [11] [12] [13] [14] [15] [16] [17] [18] [21] [22] [23] 27, 28, [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] The PIONEER study was a large prospective clinical study (n = 531) examining the role of intraoperative OCT with a microscope-mounted portable OCT system in ophthalmic surgery. 13 The DISCOVER study is a subsequent prospective clinical study (n = 227) examining microscope-integrated OCT in ophthalmic surgery. 27 Both of these studies along with several other smaller studies have helped to establish the potential clinical utility of this technology for multiple ophthalmic conditions and procedures.
Anterior segment
Intraoperative OCT has been performed for numerous anterior segment procedures, including lamellar keratoplasty, full-thickness penetrating keratoplasty, cataract surgery, corneal inlay procedures, and glaucoma surgical procedures. 9, 12, 13, 22, 23, 27, 29, 32, 39, 41, 42 Using intraoperative OCT surgeons are able to obtain immediate feedback on the status of the surgical procedure.
The PIONEER study included 275 eyes that underwent intraoperative OCT for anterior segment surgery. The majority of these (59%) cases were lamellar keratoplasty procedures. 13, 43 The DISCOVER study included 91 eyes in the anterior segment arm of the study and 64% of eyes were enrolled for a lamellar keratoplasty procedure. 27 Multiple studies, including the PIONEER and DISCOVER studies, have examined Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK) with intraoperative OCT. Graft orientation and position is easily visualized with intraoperative OCT. Subclinical interface fluid is also easily identified with intraoperative OCT (Figure 2 ). In fact, residual subclinical interface fluid at the end of the case has been associated with postoperative textural interface opacity. 39 In the DISCOVER study, intraoperative OCT findings resulted in additional surgical maneuvers in 41% of patients. 27 In the PIONEER study, intraoperative OCT identified residual persistent fluid in 48% of eyes that resulted in additional surgical maneuvers. In 18% of cases in the PIONEER study the surgeon believed there was residual fluid but intraoperative OCT confirmed complete apposition, mitigating the need for additional maneuvers. 13 This highlights the potential discordance of surgeon perception from en face visualization and surgical reality in these procedures.
In DMEK, three studies have documented the utility of intraoperative OCT during this technically challenging procedure to date. 27, 29, 41 Intraoperative OCT facilitates identification of graft orientation and appropriate unscrolling during graft manipulation. The DISCOVER study found that in~50% of cases the intraoperative OCT provided information that was discordant to surgeon impression. In addition, there is preliminary evidence that intraoperative OCT-guided DMEK may help facilitate the transition from DSAEK to DMEK for the novice DMEK surgeon. 27 In deep anterior lamellar keratoplasty (DALK), multiple studies have reported improved visualization and understanding of dissection depth with intraoperative OCT. 12, 13, 27, 32 In fact, one study reported that dissection depth measured with intraoperative OCT appeared to be an important factor for successful DALK without conversion to full-thickness penetrating keratoplasty. 12 The PIONEER and DISCOVER studies confirmed the potential role of intraoperative OCT in DALK. In some cases, intraoperative OCT identified subclinical big-bubble formation, which guided surgical maneuvers for successful dissection. In 38-56% of cases, intraoperative OCT facilitated changes in dissection depth. 13, 27 Using intraoperative OCT during cataract surgery facilitates confirmation of appropriate lens position, visualization of the corneal incision, and optimizes intraocular lens calculations. 13, 27 In fact, one study reported that intraoperative OCT-guided intraocular lens calculations are more accurate than preoperative assessment, presumably because of a more accurate identification of the post-operative lens position and calculation of anterior chamber depth. 22 
Posterior segment
For posterior segment surgical conditions, the potential for intraoperative OCT is expansive. Numerous conditions, including optic pit-related maculopathy, retinopathy of premature, macular hole, retinal detachment, proliferative diabetic retinopathy, epiretinal membrane, and posterior uveitis have been described with intraoperative OCT. [6] [7] [8] 10, [13] [14] [15] [16] [17] 21, 27, 28, 34, 35, 37, 44, 45 In selected conditions, intraoperative OCT has provided new information on the underlying pathophysiology. In retinopathy of prematurity, preretinal structures and retinoschisis have been identified with intraoperative OCT that may markedly impact the surgical approach to these complex conditions. 6 In optic pit-related maculopathy, intraoperative OCT demonstrated a potential connection between the macular schisis and the vitreous cavity. 8 In macular hole cases, the post-peel expansion of the ellipsoid zone (EZ) to retinal pigment epithelium (RPE) height may be involved in the rate of anatomic normalization following surgical repair (Figure 3) . 17, 34 In other cases, the direct and immediate feedback to surgeons can have a critical role in surgical decisionmaking and specific surgical manipulations. Membrane peeling, in particular, lends itself well to intraoperative OCT-assisted surgery. In both the PIONEER and DISCOVER study, there was a significant discordance between surgeon's microscope visualization of the pathology and the findings of the intraoperative OCT. 13, 27, 30 In 13-22% of cases, intraoperative OCT identifies residual membranes that required membrane peeling that were otherwise not identified (Figure 3) . 13, 27, 30 Conversely, in cases where the surgeon believed there was more to peel, intraoperative OCT determined that in 15-40% of cases the surgical objectives had been completed and there was not any significant residual membranes. 13, 27 Both macroarchitectural and microarchitectural changes have been described in the retina following surgical manipulations. 46 In addition procedures where direct feedback has been documented includes subretinal perfluorocarbon liquid removal and subretinal injection of therapeutics. 35 In addition, more subtle changes occur in the outer retina with expansion of the EZ-RPE height following membrane peeling.
In retinal detachment cases, subclinical persistent subretinal fluid under perfluorocarbon liquid tamponade has been identified in the vast majority of eyes undergoing surgical repair (Figure 4) . 13, 27, 35 In addition, foveal architectural changes, including occult full-thickness macular holes, have been visualized that may have prognostic implications (Figure 4) . 35 In the DISCOVER study, intraoperative OCT appeared to provide valuable information in~22% of cases, such as identification of optimal drainage sites and discriminating subretinal fluid from white without pressure. 27 For proliferative diabetic retinopathy and vitreous hemorrhage cases, intraoperative OCT can provide important insights into the anatomic configuration of the tissues. 14,27 Using a microscope-integrated system, intraoperative OCT facilitated tissue dissection by identification of surgical planes. In dense vitreous hemorrhage cases, intraoperative OCT identified a significant amount of underlying macular pathology that may potentially change intraoperative or postoperative management (for example, macular edema and intraretinal fluid). 14 
Future needs and directions
Although the last few years have seen landmark advances in the field of intraoperative OCT, continued progress is needed to overcome the current hurdles to seamless image-guided surgery. Several areas of need include OCT-compatible surgical instrumentation, automated tracking, software platforms, and a comprehensive surgeon feedback platform.
Current metallic surgical instrumentation creates difficulties for intraoperative OCT systems due to the light scattering and shadowing characteristics of metal. 19, 21, 27 This limits visualization of tissue-instrument interactions with intraoperative OCT. Novel material testing and prototype development is underway to maximize OCT-based visualization whereas maintaining the surgical precision required for ophthalmic surgery. 25 Alternatives to changes in materials could include software processing to minimize the overall impact of the instrument material on the visualization of the adjacent and underlying tissues, such as with spatial compounding. 24 Automated tracking is an additional area of need to minimize surgeon burden for manual aiming to facilitate rapid imaging of the region of interest. 47 Tracking could be performed for instrumentation and also for areas of interest on the retina away from surgical manipulation. Enhanced visualization through OCT-contrast agents, such as with triamcinolone or indocyanine green, may also be useful to improve tissue layer differentiation. 48, 49 Software analysis platforms are currently lacking on commercial devices available for intraoperative OCT. However, studies have demonstrated the ability to analyze with automated algorithms subtle perturbations in the tissues following surgical manipulation. For example, in DSAEK, automated interface fluid segmentation and fluid mapping may provide important information regarding the maximal allowed fluid for surgical success or the optimal amount to reduce the risk of post-operative textural interface fluid (Figure 2) . 50 In macular hole procedures, automated analysis of both the macular hole geometry and the outer retinal changes may impact a surgeon's understanding of hole closure rate and allow individualized care based on the intraoperative environment ( Figure 3) . 51, 52 The seamless integration of all of these tools combined with emerging OCT technology and cuttingedge visualization systems may create a new paradigm for a comprehensive image-guided surgical feedback platform for ophthalmic surgery. Using OCT-based automated assessment of relative tissue-instrument position, instrument depth information may be able to be provided to the surgeon. Novel therapeutics that demand enhanced precision may require image-assisted delivery or image-guided confirmation of optimal dosing. Last, the overall value proposition of intraoperative OCT for patient outcomes needs additional validation. Although studies have clearly demonstrated a clear impact on surgical decision, the overall impact on patient outcomes is not clear. Randomized masked prospective trials for disease-specific end points are likely needed to better define the overall value. These studies are currently being planned.
Conclusion
As OCT has revolutionized the clinical management of ophthalmic diseases, intraoperative OCT is potentially poised as a game-changing technology in the operating room. Over the past few years, significant advances in integrative technology have paved the way to first generation commercial systems. Future platforms will need to prioritize surgeon interaction, image quality, and overall data analysis to the value of this technology. Emerging therapies, such as gene therapy and stem cell therapy, may provide unique opportunities for targeted image-guided delivery with confirmatory imaging of optimal placement. Immediate surgeon feedback regarding the surgical environment may facilitate the transition to more novel procedures for surgeons. In membrane peeling procedures, intraoperative OCT may maximize surgical efficiency while minimizing unnecessary surgical manipulations. Continuing research and development is still needed for intraoperative OCT but early studies suggest that 
